Latest AI and machine learning research in alzheimer's disease for healthcare professionals.
Dementia poses a growing challenge for health services but remains stigmatized and under-recognized. Digital technologies to aid the earlier detection of dementia are approaching market. These include traditional cognitive screening tools presented on mobile devices, smartphone native applications, passive data collection from wearable, in-home and in-car sensors, as well as machine learning techn...
. This study aims to design and implement the first deep learning (DL) model to classify subjects in the prodromic states of Alzheimer's disease (AD) based on resting-state electroencephalographic (EEG) signals.. EEG recordings of 17 healthy controls (HCs), 56 subjective cognitive decline (SCD) and 45 mild cognitive impairment (MCI) subjects were acquired at resting state. After preprocessing, we ...
This study aimed to explore nurses' perceptions towards care robots and their work experiences in caring for older adults who use socially assistive t...
INTRODUCTION: Machine learning research into automated dementia diagnosis is becoming increasingly popular but so far has had limited clinical impact....
Alzheimer's disease (AD) is the most common form of dementia. Computer-aided diagnosis (CAD) can help in the early detection of associated cognitive i...
Every year, millions of brain magnetic resonance imaging (MRI) scans are acquired in hospitals across the world. These have the potential to revolutio...
Although medical research has been performed predominantly on men both in preclinical and clinical studies, continuous efforts have been made to overc...
INTRODUCTION: It is critical to develop accurate and universally available biomarkers for dementia diseases to appropriately deal with the dementia pr...
Artificial intelligence (AI) is becoming increasingly important in healthcare. This development triggers serious concerns that can be summarized by si...
OBJECTIVE: Neuropsychologists widely use the Rey-Osterrieth complex figure test (RCFT) as part of neuropsychological test batteries to evaluate cognit...
Metabolic flux augmentation via glucose transport activation may be desirable in glucose transporter 1 (Glut1) deficiency syndrome (G1D) and dementia,...
The gap between chronological age (CA) and biological brain age, as estimated from magnetic resonance images (MRIs), reflects how individual patterns ...
Alzheimer's Disease is the most common cause of dementia. Accurate diagnosis and prognosis of this disease are essential to design an appropriate trea...
Previous research has shown the benefits of early detection and treatment of dementia. This detection is usually performed manually by one or more cli...
Deep learning (DL) on brain magnetic resonance imaging (MRI) data has shown excellent performance in differentiating individuals with Alzheimer's dise...
Genetic disorders are the result of mutation in the deoxyribonucleic acid (DNA) sequence which can be developed or inherited from parents. Such mutati...
BACKGROUND: Cognitive tests and biomarkers are the key information to assess the severity and track the progression of Alzheimer's' disease (AD) and A...
BACKGROUND: Beta amyloid in the brain, which was originally confirmed by post-mortem examinations, can now be confirmed in living patients using amylo...
BACKGROUND: Alzheimer's disease has become one of the most common neurodegenerative diseases worldwide, which seriously affects the health of the elde...
BACKGROUND: Social robots have demonstrated promising outcomes in terms of increasing the social health and well-being of people with dementia and mil...